Journals / Tüberküloz ve Toraks / 2015 / Cilt: 63 - Sayı: 4

Mdr ve Xdr Mycobacterium tuberculosis örneklerinden streptomisin direncinden sorumlu rpsL ve rrs gen mutasyonlarının analizi

Analysis of rpsL and rrs genes mutations related to streptomycin resistance in Mdr and Xdr clinical isolates of Mycobacterium tuberculosis

Pages
235–242
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Streptomycin resistance is mainly related to mutation at codons 43 and 88 "rpsL" gene and to a lesser extent "rrs" that are the greatest cause of drug resistance to streptomycin.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Streptomycin is a bactericidal and aminoglycoside antibiotic.
📊
Key Findings & Data:Material and Method: In this study, among 105 strains of phlegm-positive and culture-positive Mycobacterium tuberculosis, 45 strains of resistant and sensitive to streptomycin were selected for possible mutations examination in genes rrs and rpsL.
💡
Conclusion & Impact:Conclusions: Streptomycin resistance is mainly related to mutation at codons 43 and 88 "rpsL" gene and to a lesser extent "rrs" that are the greatest cause of drug resistance to streptomycin.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Streptomycin is a bactericidal and aminoglycoside antibiotic. It is one of the most effective drugs for treatment of multidrug Tuberculosis disease. Incidence of resistance is increasingly reported. Its action mechanism is by inhibition of binding aminoacyl tRNA to position "A" in elongation phase, which finally it causes to stop bacterial protein synthesis. In this study, resistance rapid investigation to streptomycin was conducted in clinical strains of Mycobacterium tuberculosis. Material and Method: In this study, among 105 strains of phlegm-positive and culture-positive Mycobacterium tuberculosis, 45 strains of resistant and sensitive to streptomycin were selected for possible mutations examination in genes rrs and rpsL. Specific primers that used for PCR were named rpsL 1, rpsL 2 and rrsR, Frrs. PCR products were sequenced. Results: PCR Products represents 504 bp band for gene rpsL and 1027 bp for gene rrs that shows proper selection of primers and determining an amplification appropriate program. From 26 resistant strains to streptomycin 26 strain have mutation in rpsL gene and 1 strain have alteration in rrs gene. In this study 19 strains were sensitive to streptomycin that have no mutation in these gene. Conclusions: Streptomycin resistance is mainly related to mutation at codons 43 and 88 "rpsL" gene and to a lesser extent "rrs" that are the greatest cause of drug resistance to streptomycin.

Özet

Giriş: Streptomisin, çok ilaca dirençli tüberküloz tedavisinde en etkili ilaçlardan birisidir. Bakterisidal aminoglikozid bir antibiyotiktir ve direnç giderek artmaktadır. Streptomisinin etki mekanizması aminoaçil tRNA'nın uzama fazında "A"ya bağlanmasını engeller ve sonuç olarak bakteriyel protein sentezini durdurur. Bu çalışmada Mycobacterium tuberculosis'in klinik örneklerinde streptomisin direncinin hızlı incelemesi çalışılmıştır. Materyal ve Metod: Bu çalışmada balgam ve kültür pozitif 105 M. tuberculosis'ten 45 tane streptomisine dirençli ve duyarlı örnek seçilmiş ve rrs ve rpsL genlerindeki mutasyonlar açısından çalışılmıştır. Polimeraz zincir reaksiyonu (PCR) için kullanılan spesifik primerler rpsL 1, rpsL 2, rrsR ve Frrs olarak adlandırılmıştır. PCR ürünleri sekanslanmıştır.Bulgular: rpsL geni için 504 bp bandı ve rrs geni için 1027 bp bandı gösteren PCR ürünleri, uygun primerlerin seçimi ve uygun amplifikasyon programını sağlamıştır. Streptomisine dirençli 26 örnekten 26'sında spsL geninde mutasyon ve birinde rrs geninde değişklik vardı. Bu çalışmada streptomisine duyarlı 19 örnekte mutasyon saptanmadı.Sonuç: Streptomisin direncinden spsL geninde 43 ve 88 kodonlarda ve nadiren rrs genindeki mutasyonlar sorumludur.

🔖

Cite This Article

ARJOMANDZADEGAN, M., GRAVAND, S. (2022). Mdr ve Xdr Mycobacterium tuberculosis örneklerinden streptomisin direncinden sorumlu rpsL ve rrs gen mutasyonlarının analizi. Tüberküloz ve Toraks, Cilt: 63 - Sayı: 4, 235–242. https://ajindex.com/articles/618558

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Meya DB, McAdam KP. The TB pandemic: an old problem seeking new solutions J Intern Med 2007;261:309-29.
  2. Fair E, Hopewell PC, Pai M. International Standards for Tuberculosis Care: revisiting the cornerstones of tuberculosis care and control. Expert Rev Anti Infect Ther 2007;5:61-5.
  3. Finken M, Kirschner P, Meier A, Wrede A, Böttger EC. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: Alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol Mol Microbiol 1993;9:1239-46.
  4. Zignol M, Wright A, Jaramillo E, Nunn P, Raviglione MC. Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis 2007;44:61. Tracevska T, Jansone I, Nodieva A, Marga O, Skenders G, Baumanis V. Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 2004;155:830-4.
  5. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, Musser JM. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities Antimicrob Agents Chemother 1996;40:1024-6.
  6. Fukuda M, Koga H, Ohno H, Yang B, Hirakata Y, Maesaki S, et al. Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan. J Antimicrob Chemother 1999;43: 281-4.
  7. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, Musser JM. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 1996;40:1024-6.
  8. Ozturk CE, Sanic A, Kaya D, Ceyhan I. Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Düzce, Turkey. Jpn J Infect Dis 2005;58:309- 12. Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995;171:954-60.
  9. Kam KM, Yip CW, Tse LW, Leung KL, Wong KL, Ko WM, et al. Optimization of variable number tandem repeat typing set for differentiating Mycobacterium tuberculosis strains in the Beijing family. FEMS Microbiol Lett 2006;256:258-65.
  10. Dobner P, Bretzel G, Rüsch-Gerdes S, Feldmann K, Rifai M, Löscher T, et al. Geographic variation of the predictive values of genomic mutat